COYA 303 is an investigational biologic combination of COYA 301, Coya’s low-dose interleukin 2 (LD IL-2) and a GLP-1 receptor agonist (GLP-1RA), designed to deliver a multi-targeted immunomodulatory ...

The loss of the identity of insulin-secreting beta cells in the islet of Langerhans, a process also called beta cell dedifferentiation, has been proposed to be a main reason for the development of ...

Phase 1/2 trial found that six months of daily growth hormone plus biweekly testosterone was safe, well-tolerated, and produced meaningful gains in men with facioscapulohumeral muscular dystrophy ...

Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09) Among 222 patients randomly ...

-Combination of lumacaftor and ivacaftor is the first regimen designed to treat the underlying cause of CF in people with two copies of the F508del mutation, the most common form of the disease- -All ...

TORONTO—Twelve-month results of the Spare-the-Nephron study show that a regimen that spares calcineurin inhibitors (CNI) can improve renal allograft function and glomerular filtration rate (GFR). The ...

Preterm babies given a supplement with a combination of omega-3 and omega-6 fatty acids have better visual function by the age of two and a half. This has been shown by a study at the University of ...